|
| Morgan Similuk | Georgetown Lombardi Comprehensive Cancer Center (MKI, MDS) and Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research (MKI, Georgetown University, Icahn School of Medicine at Mount Sinai, Reykjavik University, Iceland (HBV) School of Medicine, University of Maryland, MD (RN) National Institute of Allergy and Infectious Diseases, National Institutes of Health, Inova Translational Medicine Institute, Inova Health System, TN (GH) Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine, WM) Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute-Harvard Medical School, SM) Center for Cancer Risk Assessment, Massachusetts General Hospital Cancer Center, MA (SM) Carol G. Simon Cancer Center, Atlantic Health Services, NJ (JH) University of Utah School of Medicine and Huntsman Cancer Institute, University of New Mexico Cancer Center |
| Claudine Isaacs | Georgetown Lombardi Comprehensive Cancer Center (MKI, MDS) and Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research (MKI, Georgetown University, Icahn School of Medicine at Mount Sinai, Reykjavik University, Iceland (HBV) School of Medicine, University of Maryland, MD (RN) National Institute of Allergy and Infectious Diseases, National Institutes of Health, Inova Translational Medicine Institute, Inova Health System, TN (GH) Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine, WM) Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute-Harvard Medical School, SM) Center for Cancer Risk Assessment, Massachusetts General Hospital Cancer Center, MA (SM) Carol G. Simon Cancer Center, Atlantic Health Services, NJ (JH) University of Utah School of Medicine and Huntsman Cancer Institute, University of New Mexico Cancer Center |
| Judy E Garber | Georgetown Lombardi Comprehensive Cancer Center (MKI, MDS) and Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research (MKI, Georgetown University, Icahn School of Medicine at Mount Sinai, Reykjavik University, Iceland (HBV) School of Medicine, University of Maryland, MD (RN) National Institute of Allergy and Infectious Diseases, National Institutes of Health, Inova Translational Medicine Institute, Inova Health System, TN (GH) Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine, WM) Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute-Harvard Medical School, SM) Center for Cancer Risk Assessment, Massachusetts General Hospital Cancer Center, MA (SM) Carol G. Simon Cancer Center, Atlantic Health Services, NJ (JH) University of Utah School of Medicine and Huntsman Cancer Institute, University of New Mexico Cancer Center |
| Stephen M Schwartz | Georgetown Lombardi Comprehensive Cancer Center (MKI, MDS) and Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research (MKI, Georgetown University, Icahn School of Medicine at Mount Sinai, Reykjavik University, Iceland (HBV) School of Medicine, University of Maryland, MD (RN) National Institute of Allergy and Infectious Diseases, National Institutes of Health, Inova Translational Medicine Institute, Inova Health System, TN (GH) Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine, WM) Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute-Harvard Medical School, SM) Center for Cancer Risk Assessment, Massachusetts General Hospital Cancer Center, MA (SM) Carol G. Simon Cancer Center, Atlantic Health Services, NJ (JH) University of Utah School of Medicine and Huntsman Cancer Institute, University of New Mexico Cancer Center |